Panacea Biotec LTD
₹354.00▼ -6.50 (-1.80%)
PANACEABIO·NSE·Healthcare
Market Cap
2203.19 Cr
PE Ratio
-266.00
Volume
32,719
Day High - Low
363.00 - 354.00
52W High-Low
647.00 - 292.40
₹354.00▼ -6.50 (-1.80%)
Market Cap2203.19 Cr
PE Ratio-266.00
Volume32,719
Day High - Low363.00 - 354.00
52W High-Low647.00 - 292.40
Panacea Biotec Ltd (PANACEABIO): company summary
The company's revenue grew 14.4% annually, reaching ₹640 crore, but annual net profit remained a loss of ₹7 crore, narrowing from a ₹9 crore loss.
Panacea Biotec Ltd (PANACEABIO) is a micro-cap Healthcare company valued at ₹2,203 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Panacea Biotec Ltd last traded at ₹354, modestly down 1.80% on the day.
- Recent developments
- On 2026-08-05, the company secured a ₹78 crore vaccine supply contract from UNICEF under a long-term Polio Supply Agreement, which strengthens its position in the global public health market.
- Financial performance
- The company's revenue grew 14.4% annually, reaching ₹640 crore, but annual net profit remained a loss of ₹7 crore, narrowing from a ₹9 crore loss. The latest quarter saw revenue rise 19.7% year-on-year to ₹200 crore, but net profit fell 44.4% to ₹2 crore.
- Valuation multiples
- A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 2.85 times book value.
- Things to watch
- The company reported a net loss of ₹7 crore in its latest financial year, and the latest quarter net profit fell 44.4% to ₹2 crore. The stock is 44.5% below its 52-week high.
- Where it stands
- The company's revenue grew 14.4% annually, but net profit remained a loss of ₹7 crore. The latest quarter saw revenue rise 19.7% year-on-year, but net profit fell 44.4% to ₹2 crore. The stock is 44.5% below its 52-week high.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
0.3/10
Poor
Fair Value
Sign in to see
ROE
-0.64%
Weak
P/E
-266.00x
Loss-making
Debt / Equity
0.03
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Poor
Price performance
Day₹354.00
₹363.00
52W₹292.40
₹647.00
DocStoX take
Held back by growth (0.2).
DocStoX score
Low confidence0.3
/10
Poor
Quality
Weak
ROE -0.6%
Valuation
Fair
P/B 2.9× on assets (no earnings to value)
Growth
Flat
Revenue +0.5% 5Y CAGR
Risk
Moderate
D/E 0.03
Momentum
Weak
17% of 52-week range
At a glance
Market Cap
₹2,203 Cr
52W High / Low
₹647 / ₹292
Dividend Yield
0.00%
Promoter Holding
72.48%
EPS (TTM)
₹-0.88
Book Value
₹136.19
Key highlights
- Low leverage — D/E 0.03
- Loss-making — no meaningful P/E
- Loss-making in some of the last 5 years
1 Positive4 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore PANACEA BIOTEC LTD’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
PANACEA BIOTEC LTD peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LAPOLLO HOSPITALS ENTER. LZYDUS LIFESCIENCES LTDLAURUS LABS LIMITEDCIPLA LTDDR. REDDY S LABORATORIESAUROBINDO PHARMA LTDMANKIND PHARMA LIMITEDLUPIN LIMITEDMANIPAL HEALTH ENTERPRI L
Compare PANACEA BIOTEC LTD with peers
Related tools & concepts
Value PANACEA BIOTEC LTD with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing